Blog

WELCOME TO OUR BLOG PAGE

       BUY D’OXYVA

FILTER BY CATEGORY

July 27, 2019

Circularity Healthcare Negotiating $100 million Institutional Funding, Expands Successful D’OXYVA Phase 3 Diabetic Foot Ulcer Treatment Clinical Trials, Expects Fast-Track FDA Approval

Read Article in PRWeb [Los Angeles, CA, July 16, 2019] Circularity Healthcare LLC, developer and manufacturer of transdermal drug delivery and wound healing products, has announced that the company has entered
Uncategorized
Read More

May 8, 2019

Circularity Enters Talks to Close Institutional Financing Round, Announces Phase 3 Clinical Research and Human Trials of Diabetic Foot Ulcer Treatment and Microcirculation at Multiple Sites in Seven Countries

Read article in PRWEB Los Angeles, CA May 8, 2019 Circularity Healthcare is emerging from a successful conference on Microcirculation in Maastricht, the Netherlands, organized by the European Society for
Company News
Read More

April 9, 2019

Circularity Healthcare Presenting D’OXYVA Diabetic Wound Healing Microcirculation Therapy Clinical Evidence and Sponsoring the 3rd International Microcirculation Conference – ESM-EVBO 2019

It is with our great pleasure to announce that we were invited by the organizers to participate in the 3rd joint ESM-EVBO 2019 and become a sponsor. The 2019 ESM-EVBO
Company News
Read More

February 19, 2019

Have you heard of Tere’s inspiring diabetic story?

Article, Diabetes, User Story
Read More

February 1, 2019

Patients are transforming from passive recipients of healthcare services to active participants in their own health

This is a preview of a research report from Business Insider Intelligence, Business Insider’s premium research service. To learn more about Business Insider Intelligence, click here. Current subscribers can read the report here. The
Article
Read More

Leave a Reply